Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Alpha-lipoic acid may prevent or lessen hearing loss caused by cisplatin.
PURPOSE: This randomized clinical trial is studying the effectiveness of alpha-lipoic acid in
preventing hearing loss in cancer patients undergoing treatment with cisplatin.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development